Cost-effectiveness of COVID-19 vaccination in low- and middle-income countries
View ORCID ProfileMark J. Siedner, Christopher Alba, Kieran P. Fitzmaurice, Rebecca F. Gilbert, Justine A. Scott, Fatma M. Shebl, Andrea Ciaranello, Krishna P. Reddy, Kenneth A. Freedberg
doi: https://doi.org/10.1101/2021.04.28.21256237
Mark J. Siedner
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
2Harvard Medical School, Boston, MA, USA
3Africa Health Research Institute, KwaZulu-Natal, South Africa
4Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
MD, MPHChristopher Alba
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
BSKieran P. Fitzmaurice
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
BSRebecca F. Gilbert
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
BAJustine A. Scott
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
MPHFatma M. Shebl
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
MD, MPHAndrea Ciaranello
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
2Harvard Medical School, Boston, MA, USA
4Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
5Harvard University Center for AIDS Research, Cambridge, MA, USA
MD, MPHKrishna P. Reddy
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
2Harvard Medical School, Boston, MA, USA
6Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
MD, MSKenneth A. Freedberg
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
2Harvard Medical School, Boston, MA, USA
4Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
7Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
8Harvard T.H. Chan School of Public Health, Boston, MA, USA
MD, MSc
Posted May 02, 2021.
Cost-effectiveness of COVID-19 vaccination in low- and middle-income countries
Mark J. Siedner, Christopher Alba, Kieran P. Fitzmaurice, Rebecca F. Gilbert, Justine A. Scott, Fatma M. Shebl, Andrea Ciaranello, Krishna P. Reddy, Kenneth A. Freedberg
medRxiv 2021.04.28.21256237; doi: https://doi.org/10.1101/2021.04.28.21256237
Cost-effectiveness of COVID-19 vaccination in low- and middle-income countries
Mark J. Siedner, Christopher Alba, Kieran P. Fitzmaurice, Rebecca F. Gilbert, Justine A. Scott, Fatma M. Shebl, Andrea Ciaranello, Krishna P. Reddy, Kenneth A. Freedberg
medRxiv 2021.04.28.21256237; doi: https://doi.org/10.1101/2021.04.28.21256237
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2944)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12750)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4586)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2918)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4359)
- Nursing (236)
- Nutrition (639)
- Oncology (2271)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (496)
- Public and Global Health (6944)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)